GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Adherium Ltd (ASX:ADRDA) » Definitions » DeferredTaxAndRevenue

Adherium (ASX:ADRDA) DeferredTaxAndRevenue : A$0.57 Mil (As of Jun. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Adherium DeferredTaxAndRevenue?

Deferred Tax And Revenue represents the current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Adherium's current deferred tax and revenue for the quarter that ended in Jun. 2024 was A$0.57 Mil.

Adherium DeferredTaxAndRevenue Historical Data

The historical data trend for Adherium's DeferredTaxAndRevenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Adherium DeferredTaxAndRevenue Chart

Adherium Annual Data
Trend Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
DeferredTaxAndRevenue
Get a 7-Day Free Trial 0.69 0.69 1.21 0.66 0.57

Adherium Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
DeferredTaxAndRevenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.21 - 0.66 - 0.57

Adherium DeferredTaxAndRevenue Related Terms

Thank you for viewing the detailed overview of Adherium's DeferredTaxAndRevenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Adherium Business Description

Traded in Other Exchanges
N/A
Address
333 Collins Street, Level 14, Melbourne, VIC, AUS, 3000
Adherium Ltd is engaged in the development, manufacture, and supply of its Hailie digital health technologies that address sub-optimal medication use and improve health outcomes in chronic disease. Geographically, it derives a majority of its revenue from Europe and also has a presence in New Zealand and Australia; North America, and Asia.

Adherium Headlines

No Headlines